Literature DB >> 18042548

Deconvoluting the Cu2+ binding modes of full-length prion protein.

Mark Klewpatinond1, Paul Davies, Suzanne Bowen, David R Brown, John H Viles.   

Abstract

The prion protein (PrP) is a cell-surface Cu(2+)-binding glycoprotein that when misfolded is responsible for a number of transmissible spongiform encephalopathies. Full-length PrP-(23-231) and constructs in which the octarepeat region has been removed, or His(95) and His(110) is replaced by alanine residues, have been used to elucidate the order and mode of Cu(2+) coordination to PrP-(23-231). We have built on our understanding of the appearance of visible CD spectra and EPR for various PrP fragments to characterize Cu(2+) coordination to full-length PrP. At physiological pH, Cu(2+) initially binds to full-length PrP in the amyloidogenic region between the octarepeats and the structured domain at His(95) and His(110). Only subsequent Cu(2+) ions bind to single histidine residues within the octarepeat region. Ni(2+) ions are used to further probe metal binding and, like Cu(2+), Ni(2+) will bind individually to His(95) and His(110), involving preceding main chain amides. Competitive chelators are used to determine the affinity of the first mole equivalent of Cu(2+) bound to full-length PrP; this approach places the affinity in the nanomolar range. The affinity and number of Cu(2+) binding sites support the suggestion that PrP could act as a sacrificial quencher of free radicals generated by copper redox cycling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042548     DOI: 10.1074/jbc.M708472200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

2.  Simulations of membrane-bound diglycosylated human prion protein reveal potential protective mechanisms against misfolding.

Authors:  Chin Jung Cheng; Heidi Koldsø; Marc W Van der Kamp; Birgit Schiøtt; Valerie Daggett
Journal:  J Neurochem       Date:  2017-05-22       Impact factor: 5.372

Review 3.  Redox control of prion and disease pathogenesis.

Authors:  Neena Singh; Ajay Singh; Dola Das; Maradumane L Mohan
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

4.  Fluorimetric analysis of copper transport mechanisms in the b104 neuroblastoma cell model: a contribution from cellular prion protein to copper supplying.

Authors:  Emanuela Urso; Antonia Rizzello; Raffaele Acierno; Maria Giulia Lionetto; Benedetto Salvato; Carlo Storelli; Michele Maffia
Journal:  J Membr Biol       Date:  2009-12-03       Impact factor: 1.843

5.  Dynamics of a truncated prion protein, PrP(113-231), from (15)N NMR relaxation: order parameters calculated and slow conformational fluctuations localized to a distinct region.

Authors:  Denis B D O'Sullivan; Christopher E Jones; Salama R Abdelraheim; Marcus W Brazier; Harold Toms; David R Brown; John H Viles
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

Review 6.  How do bacterial cells ensure that metalloproteins get the correct metal?

Authors:  Kevin J Waldron; Nigel J Robinson
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

7.  Identification of the copper(II) coordinating residues in the prion protein by metal-catalyzed oxidation mass spectrometry: evidence for multiple isomers at low copper(II) loadings.

Authors:  Rapole Srikanth; Jonathan Wilson; Colin S Burns; Richard W Vachet
Journal:  Biochemistry       Date:  2008-08-09       Impact factor: 3.162

8.  The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers.

Authors:  Nadine D Younan; Claire J Sarell; Paul Davies; David R Brown; John H Viles
Journal:  FASEB J       Date:  2013-01-18       Impact factor: 5.191

9.  Identification of the minimal copper(II)-binding alpha-synuclein sequence.

Authors:  Mark S Jackson; Jennifer C Lee
Journal:  Inorg Chem       Date:  2009-10-05       Impact factor: 5.165

10.  Copper(II) binding to alpha-synuclein, the Parkinson's protein.

Authors:  Jennifer C Lee; Harry B Gray; Jay R Winkler
Journal:  J Am Chem Soc       Date:  2008-05-09       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.